Abstract
Haematologica has published European guidelines for empirical and targeted antibacterial therapy for febrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrug resistant pathogens, and
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have